tiprankstipranks
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA

PSTX

PSTX Earnings Report this Week: Is It a Buy, Ahead of Earnings?
Pre-EarningsPSTX Earnings Report this Week: Is It a Buy, Ahead of Earnings?
4M ago
PSTX
Poseida Therapeutics Undergoes Merger and Delisting Changes
PremiumCompany Announcements
Poseida Therapeutics Undergoes Merger and Delisting Changes
6M ago
8K
PSTX
Roche Finalizes Tender Offer for $1.5B Poseida Deal
PremiumMarket News
Roche Finalizes Tender Offer for $1.5B Poseida Deal
6M ago
PSTX
Roche commences tender offer for outstanding Poseida shares at $9 per share
PremiumThe Fly
Roche commences tender offer for outstanding Poseida shares at $9 per share
7M ago
PSTX
Poseida Therapeutics highlights interim Phase 1 results for P-BCMA-ALLO1
PremiumThe Fly
Poseida Therapeutics highlights interim Phase 1 results for P-BCMA-ALLO1
7M ago
PSTX
Poseida Therapeutics downgraded to Neutral from Overweight at Piper Sandler
PremiumThe FlyPoseida Therapeutics downgraded to Neutral from Overweight at Piper Sandler
7M ago
PSTX
Poseida Therapeutics (NASDAQ:PSTX) Stock Skyrockets on News of Roche Holdings Acquisition
Premium
Market News
Poseida Therapeutics (NASDAQ:PSTX) Stock Skyrockets on News of Roche Holdings Acquisition
7M ago
PSTX
Trump threatens tariffs, Zoom reports Q3 beat: Morning Buzz
Premium
The Fly
Trump threatens tariffs, Zoom reports Q3 beat: Morning Buzz
7M ago
C
GS
Poseida Therapeutics downgraded to Neutral from Buy at H.C. Wainwright
PremiumThe Fly
Poseida Therapeutics downgraded to Neutral from Buy at H.C. Wainwright
7M ago
PSTX
Poseida downgraded to Market Perform from Outperform at William Blair
PremiumThe Fly
Poseida downgraded to Market Perform from Outperform at William Blair
7M ago
PSTX
Poseida Therapeutics downgraded to Neutral from Buy at BTIG
PremiumThe Fly
Poseida Therapeutics downgraded to Neutral from Buy at BTIG
7M ago
PSTX
Poseida Therapeutics downgraded to Neutral from Overweight at Cantor Fitzgerald
PremiumThe Fly
Poseida Therapeutics downgraded to Neutral from Overweight at Cantor Fitzgerald
7M ago
PSTX
Poseida Therapeutics to be acquired by Roche for $9.00 per share plus CVR
PremiumThe FlyPoseida Therapeutics to be acquired by Roche for $9.00 per share plus CVR
7M ago
PSTX
Poseida Therapeutics Advances in Cell Therapy Innovations
Premium
Company Announcements
Poseida Therapeutics Advances in Cell Therapy Innovations
7M ago
8K
PSTX
Poseida Therapeutics holds virtual R&D Day
Premium
The Fly
Poseida Therapeutics holds virtual R&D Day
8M ago
PSTX
Poseida Therapeutics Reports Strong Q3 2024 Progress
PremiumCompany Announcements
Poseida Therapeutics Reports Strong Q3 2024 Progress
8M ago
PSTX
Poseida Therapeutics reports Q3 EPS 21c, consensus 41c
PremiumThe Fly
Poseida Therapeutics reports Q3 EPS 21c, consensus 41c
8M ago
PSTX
Poseida Therapeutics to present data on P-KLKB1-101 in hereditary angioedema
PremiumThe Fly
Poseida Therapeutics to present data on P-KLKB1-101 in hereditary angioedema
8M ago
PSTX
Poseida Therapeutics nominates new CAR-T candidate under Roche collaboration
PremiumThe Fly
Poseida Therapeutics nominates new CAR-T candidate under Roche collaboration
8M ago
PSTX
Poseida Therapeutics reports data from Phase 1 trial of P-BCMA-ALLO1
PremiumThe FlyPoseida Therapeutics reports data from Phase 1 trial of P-BCMA-ALLO1
9M ago
PSTX
Poseida Therapeutics says FDA grants RMAT designation to P-BCMA-ALLO1
Premium
The Fly
Poseida Therapeutics says FDA grants RMAT designation to P-BCMA-ALLO1
9M ago
PSTX
Poseida Therapeutics initiates P-BCMA-ALLO1 Phase 1b trial
Premium
The Fly
Poseida Therapeutics initiates P-BCMA-ALLO1 Phase 1b trial
10M ago
PSTX

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >